Mitochondrial Fatty-Acid Oxidation Disorders
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects
BONNEFONT, J. (2004) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2004.06.004 · Cited by 637
Use of Tandem Mass Spectrometry for Multianalyte Screening of Dried Blood Specimens from Newborns
Chace, D. H., Kalas, T. A., & Naylor, E. W. (2003) · Clinical Chemistry · doi:10.1373/clinchem.2003.022178 · Cited by 621
Disorders of carnitine transport and the carnitine cycle
Longo, N., Amat di San Filippo, C., & Pasquali, M. (2006) · American Journal of Medical Genetics Part C: Seminars in Medical Genetics · doi:10.1002/ajmg.c.30087 · Cited by 543
Clayton, P. T., Eaton, S., Aynsley-Green, A., Edginton, M., Hussain, K., Krywawych, S., Datta, V., Malingré, H. E. M., Berger, R., & van den Berg, I. E. T. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11294 · Cited by 312
Chace, D. H., Hillman, S. L., Van Hove, J. L. K., & Naylor, E. W. (1997) · Clinical Chemistry · doi:10.1093/clinchem/43.11.2106 · Cited by 280
Carnitine Deficiency Disorders in Children
STANLEY, C. A. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1320.004 · Cited by 233
The Role of the Carnitine System in Human Metabolism
FOSTER, D. W. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1320.001 · Cited by 230
Mechanisms of Disease: advances in diagnosis and treatment of hyperinsulinism in neonates
De León, D. D., & Stanley, C. A. (2007) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0368 · Cited by 199
den Boer, M. E. J., Wanders, R. J. A., Morris, A. A. M., IJlst, L., Heymans, H. S. A., & Wijburg, F. A. (2002) · Pediatrics · doi:10.1542/peds.109.1.99 · Cited by 198
Amendt, B. A., Greene, C., Sweetman, L., Cloherty, J., Shih, V, Moon, A., Teel, L., & Rhead, W. J. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112953 · Cited by 170
Cited by
Carnitine transport and fatty acid oxidation
Longo, N., Frigeni, M., & Pasquali, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2016.01.023 · Cited by 996
Ward, A. J., & Cooper, T. A. (2010) · The Journal of Pathology · doi:10.1002/path.2649 · Cited by 414
Andresen, B. S., Olpin, S., Poorthuis, B. J. H. M., Scholte, H. R., Vianey-Saban, C., Wanders, R., Ijlst, L., Morris, A., Pourfarzam, M., Bartlett, K., et al. (1999) · The American Journal of Human Genetics · doi:10.1086/302261 · Cited by 305
Carnitine in the treatment of valproic acid-induced toxicity
Lheureux, P. E. R., & Hantson, P. (2009) · Clinical Toxicology · doi:10.1080/15563650902752376 · Cited by 274
Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
Pollitt, Green, McCabe, Booth, Cooper, Leonard, Nicholl, Nicholson, Tunaley, & Virdi (1997) · Health Technology Assessment · doi:10.3310/hta1070 · Cited by 267
Mitochondrial and cellular mechanisms for managing lipid excess
Aon, M. A., Bhatt, N., & Cortassa, S. C. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00282 · Cited by 253
“Defects in mitochondrial FA β-oxidation lead to several wellknown metabolic disorders, such as Reye syndrome, cardiomyopathy and sudden infant death syndrome (Roe and Ding, 2001; Yang et al., 2001).”
BackgroundPeroxisome‐mitochondria interplay and disease
Schrader, M., Costello, J., Godinho, L. F., & Islinger, M. (2015) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-015-9819-7 · Cited by 215
“While a detailed description of the cell biological and clinical aspects of the numerous mitochondrial and peroxisomal gene defects is beyond the scope of this article (see Wanders andWaterham 2006; Kompare and Rizzo 2008), a closer look at the potential reciprocal changes induced in the organelle unaffected by the ge…”
Backgroundden Boer, M. E. J., Wanders, R. J. A., Morris, A. A. M., IJlst, L., Heymans, H. S. A., & Wijburg, F. A. (2002) · Pediatrics · doi:10.1542/peds.109.1.99 · Cited by 198
MOXI Is a Mitochondrial Micropeptide That Enhances Fatty Acid β-Oxidation
Makarewich, C. A., Baskin, K. K., Munir, A. Z., Bezprozvannaya, S., Sharma, G., Khemtong, C., Shah, A. M., McAnally, J. R., Malloy, C. R., Szweda, L. I., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.058 · Cited by 171
“In late-onset b-oxidation disease, symptoms can include skeletal muscle myopathies and exercise intolerance, cardiovascular disease, and neuropathy (Kompare and Rizzo, 2008).”
Physiological functions of peroxisome proliferator-activated receptor β
Neels, J. G., & Grimaldi, P. A. (2014) · Physiological Reviews · doi:10.1152/physrev.00027.2013 · Cited by 161
Guo, P., Furnary, T., Vasiliou, V., Yan, Q., Nyhan, K., Jones, D. P., Johnson, C. H., & Liew, Z. (2022) · Environment International · doi:10.1016/j.envint.2022.107159 · Cited by 145
Ang, J. E., Revell, V., Mann, A., Mäntele, S., Otway, D. T., Johnston, J. D., Thumser, A. E., Skene, D. J., & Raynaud, F. (2012) · Chronobiology International · doi:10.3109/07420528.2012.699122 · Cited by 138
González-Guardia, L., Yubero-Serrano, E. M., Delgado-Lista, J., Perez-Martinez, P., Garcia-Rios, A., Marin, C., Camargo, A., Delgado-Casado, N., Roche, H. M., Perez-Jimenez, F., et al. (2015) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu098 · Cited by 64
Metadata
- Authors
- Kompare, M., & Rizzo, W. B.
- Venue
- Seminars in Pediatric Neurology
- Publisher
- Elsevier BV
- Published
- 2008-09
- Volume
- 15
- Issue
- 3
- Pages
- 140-149
- ISSN
- 1071-9091 (ISSN-L)
- OpenAlex
- W2003402389
- Cited by
- 429
- References
- 41
- FWCI
- 19.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.